A2M Pharma GmbH logo

A2M Pharma GmbH

A2M Pharma GmbH (Academia to Market Pharmaceutical Development) is a spin-off from Schwarz Pharma AG. Following Schwarz Pharma's merger with UCB S.A / Belgium its research portfolio was discontinued for strategic reasons. This portfolio included low risk projects in neurology and pain. A2M Pharma was funded with the aim to continue the most promising of these projects.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.a2m-pharma.com
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Alfred-Nobel-Str. 1040789
Monheim
Germany
Email
Contact Number
+32 484 26 55 06

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/a2m-pharma” connections=”true” suffix=””]